Delivery Order SPE2DR25D1004-SPE2DR26FSVY9
Award Date 12/3/25
Potential Completion Date 12/4/25
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,101.10 to AmerisourceBergen Drug Corp on July 24, 2025, for 12,000 unit capsules of Creon (pancrelipase) in 100-count bottles. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, carrying an ultimate completion date of July 25, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply contract. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement medication, with a ceiling value of $2,979.09. This is a firm fixed price delivery order with an ultimate completion date of December 3, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count bottles, valued at $31,396.02. This firm fixed price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX, valued at $999,999,999.00 through December 2026), was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for 36,000 unit capsules of Creon DR 100s, a pancreatic enzyme replacement therapy medication. This firm fixed-price delivery order, valued at $5,376.52, is scheduled for completion by December 2, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating competitive procurement. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement medication. This firm fixed-price delivery order, valued at $13,662.64, represents a non-set-aside competitive award with an ultimate completion date of December 2, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement medication. This firm fixed-price delivery order, valued at $11,775.31, represents a competitively awarded contract with an ultimate completion date of August 29, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with no set-aside designation applied to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for 12,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count bottles, with a ceiling value of $1,195.45. This is a firm fixed price delivery order with an ultimate completion date of October 29, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Creon DR 36,000 unit capsules (100-count bottles) valued at $12,373.63. This firm fixed-price delivery order, with an ultimate completion date of December 4, 2025, represents a competitively awarded, non-set-aside contract with no small business preferences applied. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme supplement) in 100-count bottles, with a ceiling value of $17,158.94. This firm fixed-price delivery order, issued on December 5, 2025, with completion expected by December 8, 2025, represents a non-competitive, non-set-aside award under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA. The pharmaceutical will be supplied from the...
- The Defense Logistics Agency awarded a delivery order valued at $10,494.25 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s on November 17, 2025, with completion expected by November 18, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of the vendor's pharmaceutical supply support to federal military and healthcare systems. The contract was executed under a non-set-aside procurement process, underscoring AmerisourceBergen's...